Trade

with

Acasti Pharma Inc
(NASDAQ: ACST)
AdChoices
0.5300
+0.0099
+1.90%
After Hours :
-
-
-

Open

0.5250

Previous Close

0.5201

Volume (Avg)

16.77k (347.48k)

Day's Range

0.5101-0.5380

52Wk Range

0.4450-2.23

Market Cap.

55.27M

Dividend Rate ( Yield )

-

Beta

0.23

Shares Outstanding

106.26M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 446.41k

    • Net Income

    • -10.35M

    • Market Cap.

    • 55.27M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -3,001.94

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.23

    • Forward P/E

    • -8.67

    • Price/Sales

    • 200.00

    • Price/Book Value

    • 1.94

    • Price/Cash flow

    • -8.03

      • EBITDA

      • -8.77M

      • Return on Capital %

      • -26.07

      • Return on Equity %

      • -32.42

      • Return on Assets %

      • -26.07

      • Book Value/Share

      • 0.24

      • Shares Outstanding

      • 106.26M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 5.57

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 777.80

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 42.05

            • 82.75

            • Pre-Tax Margin

            • -3,001.94

            • 39.38

            • Net Profit Margin

            • -3,001.94

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 9.40

              • 2.92

              • Quick Ratio

              • 9.15

              • 2.35

              • Interest Coverage

              • -6,466.96

              • 38.02

              • Leverage Ratio

              • 1.29

              • 2.21

              • Book Value/Share

              • 0.27

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -7.27

                • 243.90

                • P/E Ratio 5-Year High

                • -54.06

                • 634.30

                • P/E Ratio 5-Year Low

                • -5.73

                • 124.82

                • Price/Sales Ratio

                • 217.39

                • 9.29

                • Price/Book Value

                • 2.11

                • 8.39

                • Price/Cash Flow Ratio

                • -8.03

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -32.42

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -26.07

                        (-87.80)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -32.33

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 0.95

                      • 1.48

                      • Asset Turnover

                      • 0.01

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -9.63M
                      Operating Margin
                      -2,156.17
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -8.03
                      Ownership

                      Institutional Ownership

                      55.14%

                      Top 10 Institutions

                      55.32%

                      Mutual Fund Ownership

                      1.98%

                      Float

                      97.67%

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fiera Capital QSSP II Investment Inc.

                      •  

                        3,233,084

                      • 0.00

                      • 1.97

                      • Fidelity® NASDAQ Composite Index® Fund

                      •  

                        18,131

                      • 0.00

                      • 0.02

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Neptune Technologies & Bioressources Inc

                      •  

                        51,942,183

                      • +25.39%

                      • 49.07

                      • Perceptive Advisors LLC

                      •  

                        2,566,785

                      • -10.55%

                      • 2.42

                      • BMO Asset Management Inc.

                      •  

                        959,556

                      • -2.06%

                      • 0.90

                      • Knight Capital Americas LLC

                      •  

                        27,780

                      • -36.93%

                      • 0.03

                      • Citadel Advisors Llc

                      •  

                        19,262

                      • -79.09%

                      • 0.02

                      • Geode Capital Management, LLC

                      •  

                        18,131

                      • 0.00%

                      • 0.02

                      • UBS Securities LLC

                      •  

                        14,868

                      • +515.91%

                      • 0.01

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      -

                      Style

                      Small Growth

                      Acasti Pharma Inc is a biotechnology company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.

                      Key People

                      Henri Harland

                      President/Secretary/Director/CEO

                      Dr. Ronald Denis

                      Director/Chairman of the Board

                      Mr. Xavier Harland

                      CFO

                      Dr. Harlan W. Waksal,M.D.

                      Vice President, Divisional/Director

                      Jean-Claude Debard

                      Director/Vice President, Divisional

                      • Acasti Pharma Inc

                      • 545 Promenade du Centropolis

                      • Laval, QC H7T 0A3

                      • CAN.Map

                      • Phone: +1 450 687-2262

                      • Fax: +1 450 687-2272

                      • acastipharma.com

                      Incorporated

                      2002

                      Employees

                      -

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: